STAHIST AD- chlorcyclizine hydrochloride and pseudoephedrine hydrochloride tablet

STAHIST AD by

Drug Labeling and Warnings

STAHIST AD by is a Otc medication manufactured, distributed, or labeled by Magna Pharmaceuticals, Inc., Nexgen Pharma, Inc. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Drug Facts

ACTIVE INGREDIENT

Active Ingredients (in each immediate-release tablet)	Purpose
Chlorcyclizine HCl 25 mg	Antihistamine
Pseudoephedrine HCl 60 mg	Nasal Decongestant

Uses

temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

• runny nose
• sneezing
• itching of the nose or throat
• itchy, watery eyes
• nasal congestion
• reduces swelling of nasal passages

Warnings

Do not exceed recommended dosage.

Do not use this product

• If you are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for two weeks after stopping the MAOI drug. If you do not know if your prescription drug contains MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

• a breathing problem such as emphysema or chronic bronchitis
• glaucoma
• heart disease
• high blood pressure
• thyroid disease
• diabetes melitus
• difficulty in urination due to enlargement of the prostate gland

Ask a doctor before use if you are taking sedatives or tranquilizers

When using this product

• excitability may occur, especially in children
• may cause drowsiness
• alcohol, sedatives and tranquilizers may increase drowsiness effect
• avoid alcoholic beverages
• use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

• nervousness, dizziness or sleeplessness occur
• symptoms do not improve within 7 days or are accompanied by fever
• new symptoms occur

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.

Directions

Do not exceed recommended dosage.

• Adults and children 12 years of age and over: 1 tablet by mouth every 6-8 hours, not to exceed 3 tablets in 24 hours, or as directed by a doctor
• Children 6 to under 12 years of age: ½ tablet by mouth every 6-8 hours, not to exceed 1½ tablets in 24 hours, or as directed by a doctor
• Children under 6 years of age: Consult a doctor

Inactive ingredients

Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate

Questions or Comments?

Call 1-888-206-5525 www.magnaweb.com

SPL UNCLASSIFIED SECTION

Rev. 10/11

PRINCIPAL DISPLAY PANEL - 25 mg/60 mg Tablet Carton

NDC: 58407-625-30

Antihistamine Nasal Decongestant

Stahist AD

Each tablet contains:
Chlorcyclizine HCl 25 mg
Pseudoephedrine HCl 60 mg

MAGNA
Pharmaceuticals, Inc.
Louisville, KY 40299

30 Tablets

Sample Package Label

INGREDIENTS AND APPEARANCE

STAHIST AD 
chlorcyclizine hydrochloride and pseudoephedrine hydrochloride tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 58407-625
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CHLORCYCLIZINE HYDROCHLORIDE (UNII: NPB7A7874U) (CHLORCYCLIZINE - UNII:M26C4IP44P)	CHLORCYCLIZINE HYDROCHLORIDE	25 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F)	PSEUDOEPHEDRINE HYDROCHLORIDE	60 mg

Inactive Ingredients
Ingredient Name	Strength
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)

Product Characteristics
Color	white	Score	2 pieces
Shape	OVAL	Size	16mm
Flavor		Imprint Code	M625
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 58407-625-30	1 in 1 BOX	12/20/2011
1		30 in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC: 58407-625-06	6 in 1 BOX	12/20/2011
2	NDC: 58407-625-01	1 in 1 BLISTER PACK; Type 0: Not a Combination Product
3	NDC: 58407-625-01	1 in 1 BLISTER PACK; Type 0: Not a Combination Product	09/01/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part341	12/20/2011

Labeler - Magna Pharmaceuticals, Inc. (620988360)

Establishment
Name	Address	ID/FEI	Business Operations
Nexgen Pharma, Inc		160356114	manufacture(58407-625)